Economic evaluation of the GENESIS-SEFH report of olaratumab with doxorubicin in soft tissue sarcoma in advanced stages
Objective: The economic evaluation of the drug olaratumab is carried out in the treatment of soft tissue sarcoma.Method: The data were analyzed following the recommendations contained in the MADRE program of the GENESIS-SEFH report model.Results: Progression free survival and overall survival res...
保存先:
| 出版年: | Farmacia Hospitalaria |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Sociedad Española de Farmacia Hospitalaria
2018
|
| 主題: | |
| オンライン･アクセス: | https://www.redalyc.org/articulo.oa?id=365962347006 https://www.redalyc.org/journal/3659/365962347006/ https://www.redalyc.org/journal/3659/365962347006/html/ https://www.redalyc.org/journal/3659/365962347006/365962347006.epub https://www.redalyc.org/journal/3659/365962347006/movil |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|